Stock Taper
SCREENER COMPARE ANY 2 STOCKS
QNCX
QUINCE THERAPEUTICS, INC.
NASDAQ
$33.75
▲ UP 3.85% (1.25)

KEY STATISTICS

Market Cap$9.40 M
52w High$910.00
52w Low$15.10
Dividend Yield—
Frequency—
P/E-0.32
Volume27.13K
Shares Out.278.41K

COMPANY

LEADERSHIP

Dirk Thye
CHIEF EXECUTIVE
Dirk Thye

COMPENSATION 2026

Salary$550,000
Stock Awards$0
Incentive Plan Pay$295,625
All Other Comp.$4,000
Total$2,493,625

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 9, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
38

PRICE TARGET

Target High$70.00
Target Low$68.00
Target Median$69.00
Target Consensus$69.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.—
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2026-06-30Reverse1:20
2026-04-13Reverse1:10

PRICE

$33.75 ▲ UP 3.85% (+$1.25)
OVERLAYS
$33.00$33.75$34.509:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM33.75

About Quince Therapeutics, Inc.

https://www.quincetx.com ↗

Quince Therapeutics, Inc. is a biopharmaceutical company developing precision bone-targeting therapeutics, with lead candidate NOV004, to treat rare and debilitating bone diseases.

INDUSTRY

Biotechnology

A SERVICE QUINCE THERAPEUTICS, INC. IS KNOWN FOR

Exploring Strategic Alternatives

After failing its Phase 3 trial for eDSP in Ataxia-Telangiectasia, Quince Therapeutics ceased development and is exploring strategic options like partnerships or mergers to maximize shareholder value.

COMPETITORS

COMPETITOR
CNSP COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 12.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.00%
HOLDERS
1
TOP 1 OF 1 · RANKED BY POSITION SIZE
Jdm Financial Group LLC
1 sh · $18

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

INSIDER TRADES

★
DIRECTOR
Lamond David
Purchase · 2.7K shares
2026-06-11
★
DIRECTOR
Senner Christopher J.
Purchase · 2.7K shares
2026-06-11
★
DIRECTOR, OFFICER: CHIEF CORP. AFFAIRS OFFICER
Roberts Brigette
Purchase · 124.8K shares
2026-05-18
★
Roberts Brigette
— · —
2026-05-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 1
OUTPERFORM 1
MARKET PERFORM 1
HOLD 1
4 GRADES IN THE LAST 12 MONTHS
Cantor Fitzgerald OVERWEIGHT Oppenheimer OUTPERFORM Citizens MARKET PERFORM D. Boral Capital HOLD

SECTORS PEERS

PEERPRICE
IFRX$2.23COMPARE
ALXO$2.00COMPARE
CNTB$2.23COMPARE
GUTS$0.66COMPARE
DTIL$7.78COMPARE
CAMP$4.15COMPARE
KLRS$4.03COMPARE
ATYR$0.54COMPARE